Kathie J. Lenzen

2018

In 2018, Kathie J. Lenzen earned a total compensation of $629.4K as Former Chief Financial Officer at Xtant Medical Holdings.

Compensation breakdown

Option Awards$524,784
Salary$104,615
Total$629,399

Lenzen received $524.8K in option awards, accounting for 83% of the total pay in 2018.

Lenzen also received $104.6K in salary.

Rankings

In 2018, Kathie J. Lenzen's compensation ranked 11,105th out of 14,244 executives tracked by ExecPay. In other words, Lenzen earned more than 22.0% of executives.

ClassificationRankingPercentile
All
11,105
out of 14,244
22nd
Division
Manufacturing
4,481
out of 5,765
22nd
Major group
Chemicals And Allied Products
1,701
out of 2,128
20th
Industry group
Drugs
1,442
out of 1,817
21st
Industry
Biological Products, Except Diagnostic Substances
278
out of 339
18th
Source: SEC filing on September 20, 2019.

Lenzen's colleagues

We found three more compensation records of executives who worked with Kathie J. Lenzen at Xtant Medical Holdings in 2018.

2018

Carl O'Connell

Xtant Medical Holdings

Chief Executive Officer

2018

Michael Mainelli

Xtant Medical Holdings

Chief Executive Officer

2018

Kevin Brandt

Xtant Medical Holdings

Chief Commercial Officer

News

In-depth

You may also like